Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Journey of remdesivir from the inhibition of hepatitis C virus to the treatment of COVID-1915
Tenofovir alafenamide fumarate10
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B10
The transformation of HIV therapy: One pill once a day9
Case study of hepatitis C virus control in Egypt: impact of access program9
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in p9
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective9
The curing regimens of HCV: A SWOT analysis7
The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir7
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults7
0.024140119552612